Valeo Financial Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Valeo Financial Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$294.17 - $371.65 $35,300 - $44,598	-120 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$249.67 - $299.48 $29,960 - $35,937	120 New	120 $35,000
Q3 2020 Oct 28, 2020	SELL	$175.56 - $226.45 $21,242 - $27,400	-121 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$118.84 - $189.72 $5,942 - $9,486	50 Added 70.42%	121 $21,000
Q1 2020 Apr 13, 2020	SELL	$98.9 - $178.34 $16,813 - $30,317	-170 Reduced 70.54%	71 $10,000
Q4 2019 Jan 24, 2020	BUY	$126.05 - $152.76 $21,428 - $25,969	170 Added 239.44%	241 $37,000
Q3 2019 Oct 15, 2019	SELL	$125.07 - $143.67 $125 - $143	-1 Reduced 1.39%	71 $9,000
Q4 2018 Jan 30, 2019	SELL	$105.09 - $137.23 $4,413 - $5,763	-42 Reduced 36.84%	72 $8,000
Q3 2018 Nov 01, 2018	SELL	$112.11 - $134.54 $224 - $269	-2 Reduced 1.72%	114 $14,000
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $2,149 - $2,462	-21 Reduced 15.33%	116 $14,000
Q1 2018 Apr 12, 2018	BUY	$98.19 - $115.2 $6,382 - $7,488	65 Added 90.28%	137 $15,000
Q4 2017 Feb 09, 2018	SELL	$100.43 - $118.09 $200 - $236	-2 Reduced 2.7%	72 $8,000
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $7,157 - $8,085	74	74 $8,000

696

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.47B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.